📰 Aim Immunotech News
Aim Immunotech News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Aim Immunotech. Real-time updates on events, politics, business and more.
April 1, 2024
AIM ImmunoTech (NYSE:AIM – Get Free Report) will issue its quarterly earnings data on Tuesday, April 2nd. AIM ImmunoTech Trading Up 6.3 % Shares of NYSE AIM opened at $0.47 on Monday. AIM ImmunoTech has a one year low of $0.32 and a one year high of $0.75. The firm has a market capitalization of […]
February 23, 2024
AIM ImmunoTech (NYSE:AIM – Get Free Report) and Poseida Therapeutics (NASDAQ:PSTX – Get Free Report) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, institutional ownership, risk, earnings, dividends and valuation. Insider and Institutional Ownership 12.8% of AIM […]
February 16, 2024
AIM ImmunoTech (NYSE:AIM – Get Free Report) and Poseida Therapeutics (NASDAQ:PSTX – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, dividends, earnings, profitability, valuation, institutional ownership and analyst recommendations. Earnings & Valuation This table compares AIM […]
November 27, 2023
AIM ImmunoTech Inc. (NYSE:AIM – Get Free Report) CEO Thomas K. Equels purchased 33,861 shares of the business’s stock in a transaction that occurred on Monday, November 27th. The stock was bought at an average cost of $0.44 per share, with a total value of $14,898.84. Following the acquisition, the chief executive officer now owns […]
November 27, 2023
AIM ImmunoTech Inc. (NYSE:AIM – Get Free Report) CEO Thomas K. Equels purchased 33,861 shares of the company’s stock in a transaction dated Monday, November 27th. The stock was purchased at an average price of $0.44 per share, with a total value of $14,898.84. Following the transaction, the chief executive officer now owns 640,697 shares […]
November 5, 2023
AIM ImmunoTech Inc. (NYSE:AIM – Get Free Report)’s stock price fell 1.7% on Friday . The company traded as low as $0.49 and last traded at $0.50. 145,706 shares were traded during mid-day trading, a decline of 5% from the average session volume of 152,906 shares. The stock had previously closed at $0.51. AIM ImmunoTech […]
October 15, 2023
AIM ImmunoTech Inc. (NYSE:AIM – Get Free Report) shares were up 5.8% during mid-day trading on Friday . The stock traded as high as $0.49 and last traded at $0.49. Approximately 36,750 shares were traded during trading, a decline of 76% from the average daily volume of 156,120 shares. The stock had previously closed at […]
October 15, 2023
AIM ImmunoTech Inc. (NYSE:AIM – Get Free Report) traded up 5.8% during trading on Friday . The stock traded as high as $0.49 and last traded at $0.49. 36,750 shares traded hands during trading, a decline of 76% from the average session volume of 156,120 shares. The stock had previously closed at $0.46. AIM ImmunoTech […]
June 8, 2023
Shares of AIM ImmunoTech Inc. (NYSE:AIM – Get Rating) shot up 1.1% on Monday . The company traded as high as $0.46 and last traded at $0.45. 61,917 shares traded hands during trading, a decline of 65% from the average session volume of 177,598 shares. The stock had previously closed at $0.45. AIM ImmunoTech Price […]
April 22, 2023
AIM ImmunoTech Inc. (NYSE:AIM – Get Rating)’s stock price fell 3.3% on Thursday . The company traded as low as $0.51 and last traded at $0.52. 140,145 shares were traded during mid-day trading, a decline of 37% from the average session volume of 222,790 shares. The stock had previously closed at $0.54. AIM ImmunoTech Stock […]